June 7 – 13, 2021




UPDATE: June 8, 2021

Regional Coalition Meeting
The Northwest Region Healthcare Coalition meeting for Thursday June 10 is cancelled. We will send an email with a few highlights of information that we would have covered during the meeting to the routine attendees.

Credit: Virginia Hospital & Healthcare Association

Credit: Virginia Department of Health

COVID-19 Pandemic

Information related to the pandemic can be found on our website under Current Events. We will continue to update information related to COVID-19 there.



Credit: Health & Human Services

Credit: Assistant Secretary for Preparedness and Response


Credit: Assistant Secretary for Preparedness and Response Technical Resource,                                                                                 Assistance Center, and Information Exchange

Credit: Hospital Preparedness Program



OCR Provides Technical Assistance to the State of Arizona to Ensure Crisis Standards of Care Protect Against Age and Disability Discrimination
A complaint was brought by the Arizona Center for Disability Law, the Arc of Arizona, the Arizona Center for Law in the Public Interest, the Native American Disability Law Center, and a number of national and local disability and aging advocacy groups. OCR provided technical assistance and used a collaborative process to revise the State of Arizona’s guidelines to reflect legal requirements and best practices regarding the needs of people with disabilities and older adults. This effort builds on OCR’s continuing work to ensure non-discrimination during COVID-19.

Read More »
To see Arizona’s new CSC guidelines, please visit https://www.azdhs.gov/covid19/documents/healthcare-providers-sdmac/covid-19-addendum.pdf – PDF

2. The Express – May 2021

This issue of The Express highlights the following new/updated resources:

Credit: Centers for Disease Control and Prevention




CDC Publishes Clinical Considerations: Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults

Since April 2021, increased cases of myocarditis and pericarditis have been reported in the United States after mRNA COVID-19 vaccination (Pfizer-BioNTech and Moderna). The Centers for Disease Control and Prevention (CDC) is aware of these reports, which are rare given the number of vaccine doses administered.
CDC published clinical considerations for myocarditis and pericarditis following COVID-19 vaccination. In addition, resources for the public have been added to CDC’s website that can be a resource for your patients. CDC and its partners are actively monitoring these reports by reviewing data and medical records to learn more about what happened and to see if there is any relationship to COVID-19 vaccination. Please report all cases of myocarditis and pericarditis post COVID-19 vaccination to the Vaccine Adverse Event Reporting System (VAERS).
CDC continues to recommend COVID-19 vaccination for everyone 12 years of age and older, given the greater risk of COVID-19 illness and related, possibly severe complications

Credit: U.S. Food & Drug Administration

1. Webinar on Transitioning from Use of Non-NIOSH-Approved Disposable Respirators

The U.S. Food and Drug Administration (FDA) will host a webinar to share information and answer questions about transitioning from use of non-NIOSH-approved disposable respirators. Specifically, the FDA will present information about the May 27, 2021, Update: FDA Recommends Transition from Use of Non-NIOSH-Approved and Decontaminated Disposable Respirators – Letter to Health Care Personnel and Facilities. This webinar is part of the series on Respirators and Other Personal Protective Equipment (PPE) for Health Care Personnel Use during the COVID-19 Pandemic.

  • Date: Tuesday, June 8, 2021
  • Time: 12:00-1:00 p.m. ET
  • Registration: There is no registration for this webinar. View the webinar details for call-in information.

View the Webinar Details

2. Stop Using Lepu Medical Technology SARS-CoV-2 Antigen and Leccurate Antibody Tests – FDA Safety Communication

The U.S. Food and Drug Administration (FDA) issued a safety communication to warn the public to stop using the Lepu Medical Technology SARS-CoV-2 Antigen Rapid Test Kit and the Leccurate SARS-CoV-2 Antibody Rapid Test Kit (Colloidal Gold Immunochromatography) because the FDA has serious concerns about the performance of the tests and believes there is likely a high risk of false results when using these tests.  Neither test has been authorized, cleared, or approved by the FDA.

The FDA has identified this issue as a class I recall, the most serious type of recall. The FDA is aware that these unauthorized tests were distributed to pharmacies to be sold for at-home testing by consumers as well as offered for sale directly to consumers.
Read More »

3. SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests

The SARS-CoV-2 virus has mutated over time, resulting in genetic variation in the population of circulating viral strains over the course of the COVID-19 pandemic. Molecular, antigen, and serology tests are affected by viral mutations differently due to the inherent design differences of each test. 

This page provides information regarding the impact of viral mutations on COVID-19 tests, recommendations for clinical laboratory staff and health care providers, and information about certain tests for which the FDA has identified potential impacts on performance due to SARS-CoV-2 genetic mutations. The FDA will update this page as significant new information becomes available.
Read More »

Credit: Centers for Medicare and Medicaid Services


         Credit: U.S. Department of Homeland Security 

Credit: Federal Emergency Management Agency

Credit: U.S. Fire Administration

The InfoGram

  • Five-year study now underway to determine COVID-19’s long-term impacts on first responders
  • CISA releases updates to Active Shooter Preparedness Program, encourages preparedness for gun-related violence
  • Transportation Research Board report offers insights on post-hurricane supply chain resilience from 2017 hurricanes Harvey, Irma and Maria
  • R2 Network, a nationwide public safety network connecting first responders and tech innovators, launches free learning hub
  • National Cyber Awareness System Alert (AA21-148A): Sophisticated spearphishing campaign targets government organizations, IGOs, and NGOs
  • CISA releases best practices for mapping to MITRE ATT&CK®
  • US says ransomware attack on meatpacker JBS likely from Russia
  • Azusa police computers hit by ransomware attack
  • Buyer Be Aware: Integrating Cybersecurity into the Acquisition Process

Credit: Virginia Department of Emergency Management

Course Offerings

1. ICS 300 Intermediate ICS for Expanding Incidents
This 21-hour course is designed for front-line personnel with supervisory responsibilities to serve in a command or general staff position. The curriculum includes instruction in general principles associated with incident command, along with various tabletop exercises that allow students to put this knowledge to practical use.
Read More »

2. ICS 400 Advanced ICS
This training is a 15-hour course that provides training on the advanced resource management provisions of the Incident Command System (ICS). Course topics include explaining the special management challenges of major incidents such as unified command, multi-agency coordination systems, and emergency operations centers, as well as explaining how Multi-Agency Coordination Systems (MACS) are established and interface with emergency operations centers.

Read More »

3. G191 Incident Command System/Emergency Operations Center Interface
This 8 hour course works best when delivered to Incident Command System and Emergency Operations Center personnel from the same community. The course provides an opportunity for participants to begin developing an ICS/EOC interface for their community. The course reviews ICS and EOC responsibilities and functions and depends heavily on exercises and group discussions to formulate the interface.

Read More »

1. Learn about new Assisted Living Community Accreditation Program (The Joint Commission)

A new Assisted Living Community (ALC) Accreditation Program has launched to help assisted living organizations deliver consistent and reliable care for residents. Applications will begin to be accepted on July 1.
The standards address:
       o  Environment
       o  Staffing
       o  Emergency management
       o  Dementia care
       o  Medication management
       o  Provision of care and services
       o  Process improvement
Read More »
Source: The Joint Commission

2. Upcoming Events and Opportunities hosted by NACCHO

COVID-19 Vaccine Distribution Text Messaging Strategies
June 8, 3:00-4:00 pm ET

Vaccine Equity in Action: Public Health and Primary Care Connection – Tribal Populations Highlight
June 9, 3:00-4:30 pm ET

Infection Prevention and Control in Schools
June 10, 3:00-4:00 pm ET
Source: National Association of County & City Health Officials

3. Physicians urged to prepare for mental health crisis
The Physicians Foundation has developed a tool to help physicians prepare for mental health crises.

Physician burnout is widespread in the United States. In a survey The Physicians Foundation conducted in spring 2020, 58% of physicians reported feelings associated with burnout compared to 40% of physicians in a survey the organization conducted in 2018.
Read More »
Source: Christopher Cheney of Hospital Safety Insider

4. Plan care for dialysis and other vulnerable patients stranded in a disaster
Work with your regional healthcare coalition and Health and Human Services (HHS) to identify the number of dialysis and other vulnerable patients who might show up needing critical services if water and power become scarce during a disaster.

Be prepared to coordinate with other hospitals and dialysis centers to take those patients and work with regional officials to determine when water, oxygen, and backup power resources should be pre-positioned or diverted to appropriate locations.
Read More »

Source: Erica Carbajal of Becker’s Hospital Review

5. WHO shifts naming strategy for COVID-19 variants

COVID-19 variants will now be labeled using letters of the Greek alphabet, the World Health Organization announced May 31. 
In contrast to the series of letters and numbers that make up the scientific names, the new strategy aims to make variant labels easier to remember, the WHO said. 
“Scientific names can be difficult to say and recall, and are prone to misreporting. As a result, people often resort to calling variants by their places where they are detected, which is stigmatizing and discriminatory,” the WHO said. 
For example, under the new system, the B.1.1.7 variant, which first emerged in the U.K., will now be commonly referred to as Alpha, while B.1.351, first detected in South Africa, will be called Beta. 
The organization is using the strategy to assign labels for variants of interest and variants of concern. 
The labels will mainly be used for public communication, such as media reports, while existing scientific names will continue to be used in research.
Source: Erica Carbajal of Becker’s Hospital Review